Emergence of Trichophyton tonsurans —A Retrospective Multicentre Study of the Dermatophyte Spectrum in Germany
Mycoses · 2025
DOI: 10.1111/myc.70053 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Mycoses, 2025. Verfasst von Julia Felicitas Pilz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany. Hauptthemen laut MEDLINE: Arthrodermataceae, Tinea, Trichophyton. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In mid‐2024, German media reported increasing fungal infections by Trichophyton tonsurans linked to visits to barbershops. However, epidemiological data confirming a rise in tinea capitis and tinea corporis due to Trichophyton tonsurans are lacking.
Objectives
This study assesses dermatophyte species and clinical types of infections in German university hospitals in 2018 and 2023. Patients/Methods This retrospective, multicentre study analyses mycological culture results from three Departments of Dermatology in Freiburg, Tübingen and Munich. The dermatophyte, along with the sampled body site, age and gender of the affected patient, was recorded.
Results
1915 patients (male: 66.1%; mean age: 50 ± 24 years) with a dermatophyte‐positive culture were identified. The most common dermatophyte was Trichophyton rubrum (2018: 78.7%; 2023: 66.3%) with tinea pedis and tinea unguium being the most prevalent types of infection. An increase in tinea corporis and tinea capitis was observed , with tinea capitis doubling from 4.3% to 9.3%. In 2023, Trichophyton tonsurans emerged as the prevailing dermatophyte (67.6%) in tinea capitis and as the second most frequent agent in tinea corporis (26.3%). This dominance of Trichophyton tonsurans was consistently observed across all three study centres. Trichophyton tonsurans affected patients presented a median age of 18 years in 2023 (vs. 9 years in 2018) and an amplified imbalance towards the male gender.
Conclusions
The pathogen spectrum and infection patterns have changed in Germany due to the increase of Trichophyton tonsurans infections. Intensified screening and hygiene measures, as well as adaptation of initial empiric treatment of tinea capitis, should be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Allergy, Technical University of Munich, School of Medicine and Health, Munich, Germany.
- Department of Dermatology, Eberhard Karls University of Tübingen, Tübingen, Germany.
- Department of Dermatology and Venereology, Medical Center, University of Freiburg, Freiburg, Germany.
- Christine Kühne-Center for Allergy Research and Education, Medicine Campus Davos, Davos, Switzerland.
- Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
ORCID-Profile: Sebastian Sitaru, Anna Caroline Pilz
Zitieren
APA
Pilz, J. F., Schaller, M., Köberle, M., Lorz, A., Bamarni, A., Sitaru, S., Schauer, F., Seidl, H. P., Biedermann, T., Zink, A., Eyerich, K., & Pilz, A. C. (2025). Emergence of Trichophyton tonsurans —A Retrospective Multicentre Study of the Dermatophyte Spectrum in Germany. Mycoses. https://doi.org/10.1111/myc.70053
Vancouver
Pilz JF, Schaller M, Köberle M, Lorz A, Bamarni A, Sitaru S, et al. Emergence of Trichophyton tonsurans —A Retrospective Multicentre Study of the Dermatophyte Spectrum in Germany. Mycoses. 2025. doi:10.1111/myc.70053
BibTeX
@article{Pilz2025,
author = {Pilz, Julia Felicitas and Schaller, Martin and Köberle, Martin and Lorz, Alexandra and Bamarni, Avend and Sitaru, Sebastian and Schauer, Franziska and Seidl, Hans Peter and Biedermann, Tilo and Zink, Alexander and Eyerich, Kilian and Pilz, Anna Caroline},
title = {Emergence of Trichophyton tonsurans —A Retrospective Multicentre Study of the Dermatophyte Spectrum in Germany},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70053}
}
EUVIMED